FDA Issues Warning Against Smart Watches for Blood Sugar Monitoring

WASHINGTON: The US Food and Drug Administration (FDA) issued a warning against the use of smart watches or rings claiming to measure blood sugar levels without piercing the skin. Regardless of the manufacturer or brand, the FDA cautioned against the use of these devices, emphasizing the risk of inaccurate measurements and potential life-threatening errors in diabetes management. The agency clarified that it has not authorized or approved any smartwatch or smart ring for independent blood glucose level measurement. The FDA is actively working to prevent the illegal marketing of unauthorized tools purported to measure blood sugar levels.